相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months
Renate J. Schoemakers et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2019)
Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths
Wayne A. Ray et al.
JAMA PSYCHIATRY (2019)
Antipsychotics in Dutch Youth: Prevalence, Dosages, and Duration of Use from 2005 to 2015
Sanne M. Kloosterboer et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2018)
Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain
Frederik Vandenberghe et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2018)
Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-Analysis
Pierre Ellul et al.
CNS DRUGS (2018)
The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression
Edwin F. Liang et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)
Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Ole J. Storebo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics A Systematic Review and Meta-analysis
Britta Galling et al.
JAMA PSYCHIATRY (2016)
Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents A Bayesian Meta-Analysis
David Cohen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
M. De Hert et al.
EUROPEAN PSYCHIATRY (2011)
Antipsychotic drugs and obesity
Christoph U. Correll et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Management of antipsychotic-related weight gain
Lawrence Maayan et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene
Pieter J. Hoekstra et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2010)
Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study
Magali Haas et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Weight Gain and Metabolic Abnormalities During Extended Risperidone Treatment in Children and Adolescents
Chadi A. Calarge et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent? A Literature Review
Viktoria Simon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
Wayne A. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Understanding the relationship between baseline BMI and subsequent weight change in antipsychotic trials: Effect modification or regression to the mean?
David B. Allison et al.
PSYCHIATRY RESEARCH (2009)
Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents
Roger S. McIntyre et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2008)
Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes
Christoph U. Correll
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2008)
Tracking of childhood overweight into adulthood: a systematic review of the literature
A. S. Singh et al.
OBESITY REVIEWS (2008)
A comparison of risperidone-induced weight gain across the age span
DJ Safer
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data
A Martin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders
RL Lindsay et al.
CLINICAL PEDIATRICS (2004)
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ
MG Aman et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2004)
Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study
G Ratzoni et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
分享论文
